Online physician social network Sermo.com, now with 10,000 members, is becoming an increasingly important venue for many doctors, enabling them to connect to colleagues across the country at a moment's notice, share insights and experiences, and generate debate. Sermo colleagues are allowed to rank the relevance of each observation as a way to quickly surface key trends and insights.
Recent postings regarding pharma products include:
- Do you agree with Novartis discontinuing Zelnorm?
- Is Cymbalta good for Fibromyalgia?
- FDA sleeping pill warnings -- Have they gone too far?
Full Article from GovTech.net